AdaptHealth Corp. (AHCO) director adds 23,500 shares in open-market purchase

Rhea-AI Filing Summary

AdaptHealth Corp. director Kenneth A. Samet purchased additional common stock in an open-market or private transaction. On 2026-08-06 he bought 23,500 shares at $6.38 per share, bringing his directly held position to 48,569 shares of AdaptHealth common stock.

Insider Trade Summary

Net Buyer: 23,500 shares

Net Buy 1 txn

Insider SAMET KENNETH A

Role Director

Bought 23,500 shs ($150K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	23,500	$6.38	$150K

Holdings After Transaction: Common Stock — 48,569 shares (Direct)

Key Figures

Shares purchased: 23,500 shares Purchase price: $6.38 per share Shares held after transaction: 48,569 shares

3 metrics

Shares purchased 23,500 shares Common stock purchase on 2026-08-06

Purchase price $6.38 per share Common stock transaction on 2026-08-06

Shares held after transaction 48,569 shares Direct ownership following reported purchase

Key Terms

Form 4, open market or private transaction, Power of Attorney

3 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open market or private transaction financial

"transaction_code_description": "Purchase in open market or private transaction""

Power of Attorney regulatory

"The Power of Attorney given by the reporting person was previously filed"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/10/2026 - 08:03 PM Accepted by SEC EDGAR 08/10/2026 - 08:03 PM Learn about SEC filing dates

FAQ

What insider transaction did AdaptHealth (AHCO) report for Kenneth A. Samet?

AdaptHealth reported that director Kenneth A. Samet purchased 23,500 shares of common stock on 2026-08-06 in an open-market or private transaction, increasing his directly held position in the company.

At what price did Kenneth A. Samet buy AdaptHealth (AHCO) shares?

Kenneth A. Samet purchased AdaptHealth common stock at an average price of $6.38 per share. The reported transaction involved 23,500 shares, classified as a purchase in an open-market or private transaction.

How many AdaptHealth (AHCO) shares does Kenneth A. Samet hold after this trade?

Following the reported transaction, Kenneth A. Samet directly holds 48,569 shares of AdaptHealth common stock. This figure reflects his position immediately after buying 23,500 shares on 2026-08-06.

Was the AdaptHealth (AHCO) insider purchase made under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox was not marked, so the 23,500-share purchase by Kenneth A. Samet on 2026-08-06 was not reported as being made under a trading plan.

What type of security did Kenneth A. Samet buy in AdaptHealth (AHCO)?

Kenneth A. Samet bought common stock of AdaptHealth Corp. The Form 4 lists a single non-derivative transaction, described as a purchase in an open-market or private transaction at $6.38 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SAMET KENNETH A

(Last) (First) (Middle)

C/O ADAPTHEALTH CORP.

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2026		P		23,500	A	$6.38	48,569	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 26, 2026 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Kenneth A. Samet	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)